Here’s a retraction from Stem Cells and Development that we’re just now getting around to covering. The paper, “Non-viral reprogramming of skeletal myoblasts with valproic acid for pluripotency,” appeared in June 2012 in a preliminary online form and was written by a group at the University of Cincinnati. As the retraction notice states: Continue reading Retraction for stem cell scientist facing misconduct inquiry
Category: basic life sciences retractions
Fernández genetics paper in limbo over data concerns
Ariel Fernández, the protein researcher whose theories of drug design lately have come in for questioning, has lost a paper, at least for the moment.
The article, “Supramolecular Evolution of Protein Organization,” appeared online in Annual Reviews of Genetics prior to print. It lists Fernández’s affiliation as ProWD Sciences, in Madison, Wisc. Not much exists on the web about that company, however, except an under-construction site. (ProWD, by the way, is short for PROtein-Water-Dehydron, Fernández’s area of interest.)
Here’s the notice: Continue reading Fernández genetics paper in limbo over data concerns
“Ambiguities in the presentation of some of the data” lead to an ambiguous retraction notice
Sometimes, authors and journals editors seem to think a bit of mystery is a good thing. Take a recent retraction in Brain.
Here’s the notice for “Selective impairment of hand mental rotation in patients with focal hand dystonia:” Continue reading “Ambiguities in the presentation of some of the data” lead to an ambiguous retraction notice
Pamela Ronald does the right thing again, retracting a Science paper
About a month ago, we reported on a retraction by Pamela Ronald, of the University of California, Davis, and colleagues. We noted then that this was a case of scientists doing the right thing. Ronald contacted us after that post ran, and let us know that there would be another retraction shortly. That retraction notice has now appeared, in Science: Continue reading Pamela Ronald does the right thing again, retracting a Science paper
Embryonic stem cell paper retracted for fabrication
Stem Cells and Development has retracted a paper it published earlier this year after the leader of the study reported that the data were unreliable.
The paper, “Derivation and Genetic Modification of Embryonic Stem Cells from Disease-Model Inbred Rat Strains,” came from the lab of Aron Geurts, of the Medical College of Wisconsin.
According to the retraction notice: Continue reading Embryonic stem cell paper retracted for fabrication
Aoki notches fourth retraction for image problems
We have a fourth retraction in the Journal of Biochemistry for Naohito Aoki, a Japanese researcher and former postdoc in a German lab, whose images have been called into question but whose retraction notices were scant. In this case, however, the journal, while not exactly overbrimming with information about the article, at least gives us some sense of what’s going on.
Aoki worked in the lab of Axel Ullrich, of the Max Planck Institute of Biochemistry, and appeared on two retracted articles in the Journal of Biological Chemistry (JBC) with his mentor, along with a third with a co-author from Japan, Tsukasa Matsuda. Although those notices don’t say anything about the reason for the retractions — this was before the JBC started providing such information — Ulrich told us that Aoki had been manipulating images. Continue reading Aoki notches fourth retraction for image problems
Neuroscience journal takes tough stance on plagiarism
Like Howard Beale, the character in 1976’s “Network” who famously said “I’m as mad as hell, and I’m not going to take this anymore!,” the editors of the journal Cortex have decided they’ve had enough when it comes to plagiarism.
From an editorial in the current issue:
We will treat academic plagiarism as a misdeed, not as a mistake, and a paper that plagiarizes others will be immediately rejected and may be reported to the author’s academic affiliation.
The editors explain how: Continue reading Neuroscience journal takes tough stance on plagiarism
Spat over tuberculosis study data leads to Expression of Concern
A fight over who owns tuberculosis study data has led the Journal of Clinical Microbiology to publish an Expression of Concern.
Here’s the notice: Continue reading Spat over tuberculosis study data leads to Expression of Concern
Your bad: Journal yanks paper for plagiarism and duplication, and points fingers
Here’s a warning to would-be plagiarizers: Don’t submit to the journal Molecules unless you have no problem being called out by name when you’re busted.
Consider: The journal is retracting a paper it published earlier this year after learning that the article contained verbatim text — and lots of it — from previously published papers.
The article, “Cytotoxicity and Anti-Inflammatory Activity of ethylsulfanyltriazoloquinazolin,” was written by a group that included Amira M. Gamal-Eldeen, of the National Research Center in Cairo, Egypt. Why single out Dr. Gamal-Eldeen, you ask? Read for yourself: Continue reading Your bad: Journal yanks paper for plagiarism and duplication, and points fingers
It’s an epidemic! Another group does the right thing, retracting neuroscience paper
As the bumper sticker says, “Regime change starts at home.” Seems to be the case with scientists these days.
This month we have seen commendable instances of researchers retracting papers after identifying flaws in their own data — an outbreak of integrity that has us here at Retraction Watch applauding. (We’ve even created a new category, “doing the right thing,” at the suggestion of a reader.)
Today’s feel-good story comes from the lab of Karl Svoboda, of the Howard Hughes Medical Institute’s Janelia Farm Research Campus, in Ashburn, Va. Back in June, Svoboda and his colleagues published “Whisker Dynamics Underlying Tactile Exploration,” in the Journal of Neuroscience. Here’s what the abstract had to say about the study:
Continue reading It’s an epidemic! Another group does the right thing, retracting neuroscience paper